Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vera Therapeutics Inc (NASDAQ: VERA) closed the day trading at $41.36 down -5.81% from the previous closing price of $43.91. In other words, the price has decreased by -$5.81 from its previous closing price. On the day, 0.57 million shares were traded. VERA stock price reached its highest trading level at $44.395 during the session, while it also had its lowest trading level at $40.75.
Ratios:
For a better understanding of VERA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.60 and its Current Ratio is at 13.60. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on November 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.
On January 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.Oppenheimer initiated its Outperform rating on January 25, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 18 ’24 when MARSHALL FORDYCE bought 17,500 shares for $43.91 per share.
Fordyce Marshall sold 17,500 shares of VERA for $821,523 on Dec 11 ’24. The PRESIDENT AND CEO now owns 85,942 shares after completing the transaction at $46.94 per share. On Dec 11 ’24, another insider, MARSHALL FORDYCE, who serves as the Director of the company, bought 17,500 shares for $46.92 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2619043328 and an Enterprise Value of 2320642560.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $14.20. The 50-Day Moving Average of the stock is -8.17%, while the 200-Day Moving Average is calculated to be 1.36%.
Shares Statistics:
Over the past 3-months, VERA traded about 751.58K shares per day on average, while over the past 10 days, VERA traded about 407080 shares per day. A total of 55.03M shares are outstanding, with a floating share count of 49.05M. Insiders hold about 22.54% of the company’s shares, while institutions hold 77.47% stake in the company. Shares short for VERA as of 1732838400 were 6519748 with a Short Ratio of 8.67, compared to 1730332800 on 6389681. Therefore, it implies a Short% of Shares Outstanding of 6519748 and a Short% of Float of 13.73.
